Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
|
|
CANNAPHARMARX, INC. (CPMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 02/16/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data|
Docs:
|
"CannaPharmaRx Acquiring Oklahoma Cannabis Facility CALGARY, AB / ACCESSWIRE / February 10, 2022 / CannaPharmaRx, Inc. , a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a Letter of Intent to purchase an operating Cannabis facility located in Braman, Oklahoma. The property consists of 35,000 square feet of cultivation capacity, with a planned, phased expansion to 65,000 square feet, by the end of 2022 and up to five harvests per year. The purchase will be completed via a secured note and will include the transfer of licenses. The transaction is expected to close prior to March 31, 2022. The facility has ongoing growing and sales operations and should the deal be finalized CannapharmaRx will realize first harvest and sales fro..." |
|
| 07/16/2021 |
8-K
| Quarterly results |
| 06/22/2021 |
8-K
| Quarterly results |
| 06/09/2021 |
8-K
| Quarterly results |
| 01/28/2021 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/22/2021 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Commitment Letter",
"CannapharmaRx, Inc. Announces Non-Dilutive Commitment Financing for Assets and Facilities Located in Cremona, AB CALGARY, AB / ACCESSWIRE / January 19, 2021 / CannapharmaRx, Inc. a future leader in ultramodern, highly efficient cannabis production facilities in Canada announced today that it has secured a commitment letter for twelve million dollars for the recently announced purchase of the cannabis cultivation and production business located at, and operated out of Cremona, Alberta and other acquisitions of cannabis cultivation and production facilities. The loan, which is fully collateralized by the facilities, will provide CannapharmaRx with the capital to complete the purchase of the 55,200 square foot facility, which is capable of producing 5,200 kilograms of cannabis biomass per yea..." |
|
| 01/12/2021 |
8-K
| Quarterly results |
| 08/20/2020 |
8-K
| Quarterly results |
| 07/02/2020 |
8-K
| Quarterly results |
| 06/10/2020 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Sale of Sunniva Medical to CannapharmaRx is Terminated CannapharmaRx turns its attention to acquiring a revenue producing property Calgary, Alberta, June 10, 2020 -- CannaPharmaRx, Inc. a future leader in ultramodern, highly efficient cannabis production facilities in Canada and the US, announced today that the Company has been notified by Sunniva, Inc. that it has terminated the sale of their wholly-owned subsidiaries Sunniva Medical Inc. and 1167025 B.C. LTD, to CannaPharmaRx Inc. “We are working through this termination letter and carefully weighing our options,” said Nick Colvin, CEO of CannaPharmaRx. “We have various other agreements that we are cautiously optimistic of consummating. We will update our shareholders as soon as we close an acquisition” added Colvin. About CannaPharmaRx,..." |
|
| 05/20/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 05/14/2020 |
8-K
| Other Events |
| 03/26/2020 |
8-K
| Other Events |
| 03/17/2020 |
8-K
| Quarterly results |
| 02/10/2020 |
8-K
| Quarterly results |
| 02/07/2020 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Amendment to Securities Purchase Agreement with Sunniva Inc",
"Sunniva Inc. And CannaPharmaRx, Inc. Announce Extension To Outside Date Of Share Purchase Agreement For Sale Of Sunniva Medical Inc. KELOWNA, British Columbia and VANCOUVER, British Columbia, Nov. 28, 2019 /CNW/ -- Sunniva Inc. and CannaPharmaRx Canada Corp. , a subsidiary of CannaPharmaRx, Inc. today jointly announce that they are extending the outside date of the Share Purchase Agreement previously announced on June 11, 2019 with respect to the sale of the shares of Sunniva Medical Inc. to CannaPharmaRx until December 20, 2019. The terms of the SMI Transaction, as amended on October 2, 2019, otherwise remain unchanged, with the purchase price to be satisfied by way of CAD $16.0 million in cash and CAD $4.0 million by way of a promissory note of CannaPharmaRx . The Company and CannaPharm..." |
|
| 10/02/2019 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure |
| 06/12/2019 |
8-K
| Entered into consulting agreement|
Docs:
|
"Securities Purchases Agreement by and between Cannapharmarx Canada Corp., Cannapharmarx, Inc., as Purchasers and Sunniva, Inc., as Seller",
"Agreement between KannaREIT, Inc. and Cannapharmarx, Inc",
"SUNNIVA INC. AGREES TO SELL ITS OKANAGAN FALLS PROPERTY TO CANNAPHARMARX, INC. FOR CAD $20 MILLION Transaction is subject to financial audit and satisfaction of other conditions VANCOUVER, BC – June 12, 2019 – Sunniva Inc. and CannaPharmaRx, Inc. are pleased to announce that they have entered into a share purchase agreement dated June 11, 2019, pursuant to which Sunniva has agreed to sell Sunniva Medical Inc. to CannaPharmaRx in an all-cash transaction for CAD $20 million less certain outstanding liabilities in SMI, including the mortgage on the property. Net proceeds payable to Sunniva are anticipated to be approximately CAD $15.5 million. Closing is anticipated to occur on or around July 5, 2019. Effectiveness of the agreement is subject to certain closing conditions including completi..." |
|
| 04/26/2019 |
8-K
| Appointed a new director |
| 02/28/2019 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 02/14/2019 |
8-K/A
| Quarterly results |
| 01/30/2019 |
8-K
| Quarterly results |
| 01/07/2019 |
8-K/A
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Change in Shell Company Status, Regulati...|
Docs:
|
"CANNAPHARMARX ANNOUNCES THE ACQUISITION OF ALTERNATIVE MEDICAL SOLUTIONS Company Continues its Efforts to Re-Enter Cannabis Space IRVINE, CA—[January 8, 2019]—Cannapharmarx, Inc. announced today it has completed the acquisition of Alternative Medical Solutions, Inc., , an Ontario, Canada corporation. Under the terms of the agreement Hanover CPMD Acquisition Corp. , a wholly-owned subsidiary of the Company, acquired all of the issued and outstanding securities of AMS for total consideration of CAD$12,710,000 consisting of cash, common stock, and a promissory note. AMS is a late stage marijuana licensed producer applicant in Canada currently operating in the Pre-License Inspection and Licensing phase, which is Stage 5 of 6, with a fully approved license. Upon final construction of the AMS cu..." |
|
| 11/21/2018 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 06/15/2018 |
8-K
| Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
| 04/13/2018 |
8-K
| Other Events |
| 06/01/2016 |
8-K
| Quarterly results |
| 04/15/2016 |
8-K
| Form 8-K - Current report |
| 01/27/2011 |
8-K
| Form 8-K - Current report |
| 01/11/2011 |
8-K/A
| Form 8-K - Current report [amend] |
| 11/17/2010 |
8-K
| Form 8-K - Current report |
| 10/14/2010 |
8-K
| Form 8-K - Current report |
| 01/22/2009 |
8-K
| Form 8-K - Current report |
|
|
|